Four-factor prothrombin complex concentrate for urgent reversal of vitamin K antagonists in patients with major bleeding

Circulation

Volumn 128, Issue 11, 2013, Pages 1179-1181

  Quinlan, Daniel J ^a   Eikelboom, John W ^b,c   Weitz, Jeffrey I ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b MCMASTER UNIVERSITY   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVITAMIN K; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 10A INHIBITOR; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 9; BLOOD CLOTTING FACTOR 9 CONCENTRATE; DABIGATRAN; FRESH FROZEN PLASMA; PROTHROMBIN COMPLEX; WARFARIN;

BLEEDING; BLOOD CLOTTING DISORDER; BLOOD GROUP; BLOOD VOLUME; DRUG INHIBITION; DRUG MECHANISM; EDITORIAL; HEMOSTASIS; HUMAN; HYPERVOLEMIA; INTERNATIONAL NORMALIZED RATIO; KIDNEY FUNCTION; PRIORITY JOURNAL;

EDITORIALS; HEMORRHAGE; PROTHROMBIN COMPLEX CONCENTRATES; RANDOMIZED CONTROLLED TRIAL; WARFARIN;

ANTICOAGULANTS; BLOOD COAGULATION FACTORS; DRUG COMBINATIONS; FACTOR IX; FACTOR VII; FACTOR X; FEMALE; HEMORRHAGE; HEMOSTATICS; HUMANS; MALE; PROTHROMBIN; VITAMIN K;

EID: 84884351753     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.113.005107     Document Type: Editorial

References (19)

1. Tran HA, Chunilal SD, Harper PL, Tran H, Wood EM, Gallus AS; Australasian Society of Thrombosis and Haemostasis (ASTH). An update of consensus guidelines for warfarin reversal. Med J Aust. 2013;198:198-199
2. Dentali F, Marchesi C, Pierfranceschi MG, Crowther M, Garcia D,Hylek E, Witt DM, Clark NP, Squizzato A, Imberti D, Ageno W. Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists: A meta-analysis. Thromb Haemost. 2011;106:429-438
3. Keeling D, Baglin T, Tait C, Watson H, Perry D, Baglin C, Kitchen S,Makris M; British Committee for Standards in Haematology. Guidelines on oral anticoagulation with warfarin - Fourth edition. Br J Haematol. 2011;154:311-324
4. Holbrook A, Schulman S, Witt DM, Vandvik PO, Fish J, Kovacs MJ,Svensson PJ, Veenstra DL, Crowther M, Guyatt GH; American College of Chest Physicians. Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2Suppl):e152S- e184S.
5. Spahn DR, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernández- Mondéjar E, Filipescu D, Hunt BJ, Komadina R, Nardi G, Neugebauer E, Ozier Y, Riddez L, Schultz A, Vincent JL, Rossaint R. Management of bleeding and coagulopathy following major trauma: An updated European guideline. Crit Care. 2013;17:R76
6. Aledort LM. Comparative thrombotic event incidence after infusion of recombinant factor VIIa versus factor VIII inhibitor bypass activity. J Thromb Haemost. 2004;2:1700-1708
7. Levi M, Levy JH, Andersen HF, Truloff D. Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med. 2010;363:1791-1800
8. Boulis NM, Bobek MP, Schmaier A, Hoff JT. Use of factor IX complex in warfarin-related intracranial hemorrhage. Neurosurgery. 1999;45:1113-1118
9. Demeyere R, Gillardin S, Arnout J, Strengers PF. Comparison of fresh frozen plasma and prothrombin complex concentrate for the reversal of oral anticoagulants in patients undergoing cardiopulmonary bypass surgery: A randomized study. Vox Sang. 2010;99:251-260
10. Leissinger CA, Blatt PM, Hoots WK, Ewenstein B. Role of prothrombin complex concentrates in reversing warfarin anticoagulation: A review of the literature. Am J Hematol. 2008;83:137-143
11. Pabinger I, Brenner B, Kalina U, Knaub S, Nagy A, Ostermann H; Beriplex P/N Anticoagulation Reversal Study Group. Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: A prospective multinational clinical trial. J Thromb Haemost. 2008;6:622-631
12. Imberti D, Magnacavallo A, Dentali F, Condoleo E, Gallerani M, Benedetti R, Ageno W. Emergency reversal of anticoagulation with vitamin K antagonists with 3-factor prothrombin complex concentrates in patients with major bleeding. J Thromb Thrombolysis. 2013;36:102-108
13. Hickey M, Gatien M, Taljaard M, Aujnarain A, Giulivi A, Perry JJ. Outcomes of urgent warfarin reversal with frozen plasma versus prothrombin complex concentrate in the emergency department. Circulation. 2013;128:360-364
14. Sarode R, Milling TJ Jr, Refaai MA, Mangione A, Schneider A, Durn BL, Goldstein JN. Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: A randomized, plasma-controlled, phase IIIb study. Circulation. 2013;128:1234-1243
15. Efficacy and safety study of Beriplex® P/N compared with plasma in patients with acute major bleeding caused by anticoagulant therapy. www. clinicaltrials.gov/ct2/show/NCT00708435. Accessed August 4, 2013
16. CSL Behring. Kcentra Prescribing Information, April 2013. http://www. kcentra.com/prescribing-information.aspx. Accessed August 4, 2013
17. Dager WE. Using prothrombin complex concentrates to rapidly reverse oral anticoagulant effects. Ann Pharmacother. 2011;45:1016-1020
18. Lu G, DeGuzman FR, Hollenbach SJ, Karbarz MJ, Abe K, Lee G, Luan P,Hutchaleelaha A, Inagaki M, Conley PB, Phillips DR, Sinha U. A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa. Nat Med. 2013;19:446-451
19. Schiele F, van Ryn J, Canada K, Newsome C, Sepulveda E, Park J, Nar H, Litzenburger T. A specific antidote for dabigatran: Functional and structural characterization. Blood. 2013;121:3554-3562